Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Liabilities and Shareholders Equity (2022 - 2025)

Vsee Health filings provide 4 years of Liabilities and Shareholders Equity readings, the most recent being $22.4 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 12.11% to $22.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $78.7 million, a 80.24% increase, with the full-year FY2025 number at $22.4 million, up 12.11% from a year prior.
  • Liabilities and Shareholders Equity hit $22.4 million in Q4 2025 for Vsee Health, up from $18.7 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $22.4 million in Q4 2025 to a low of $805791.0 in Q4 2023.
  • Median Liabilities and Shareholders Equity over the past 4 years was $13.2 million (2023), compared with a mean of $12.9 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: crashed 89.45% in 2023 and later surged 2381.1% in 2024.
  • Vsee Health's Liabilities and Shareholders Equity stood at $7.6 million in 2022, then crashed by 89.45% to $805791.0 in 2023, then surged by 2381.1% to $20.0 million in 2024, then grew by 12.11% to $22.4 million in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $22.4 million (Q4 2025), $18.7 million (Q3 2025), and $18.2 million (Q2 2025) per Business Quant data.